Implications of recent news flow
The recent news flow on Kinarus’ lead product KIN001 has bolstered its profile for the treatment of...
Read morePositive update on partner deals
Destiny have announced a trading update that includes a bolus of progress on the partnering of its...
Read moreRecord results sets up the future
MCH delivered record results, largely due to an exceptional performance from Marshall Motor...
Read moreRecord closing order book
For the six months to 31 October 2022, Cohort PLC reported a strong performance: revenue was up...
Read more
Resilient income streams drive H1 result
Another strong half reflects the benefits of an increasingly diverse base of cyclical and...
Read moreMessages from the interim results
RUA Life Sciences’ interim results include in-depth updates on the development of its vascular...
Read moreFY22 results deliver sustainable growth
For the year to 30 September 2022, Benchmark Holdings reported revenue of £158.3m, +27%YoY and...
Read more
Validation for microbiomes
With the first ever FDA approval for a faecal microbiome drug the door has been opened for other...
Read more
Trading update / Completion of Billi acquisition
Ongoing lockdowns in South China have impacted two of the Group’s largest OEM customers during the...
Read moreRegister to be first
Get research on the companies that interest you straight to your inbox
